Carotid Artery Stenting: Evolution, Evidence, and Contemporary Practice in the Era of Intensive Medical Therapy

Sakshi Dixit1, Fnu Anamika1, Anmol Multani2

  • 1Cleveland Clinic Akron General, Akron, OH 44307, USA.

Insights

Carotid artery stenting (CAS) and carotid endarterectomy (CEA) offer comparable outcomes for stroke prevention. Optimal treatment involves individualized decisions balancing procedural risks, benefits, and intensive medical therapy for long-term vascular health.

Area of Science:

  • Vascular Surgery
  • Neurology
  • Interventional Cardiology

Background:

  • Carotid artery stenosis is a leading cause of ischemic stroke globally.
  • Carotid endarterectomy (CEA) is the standard for symptomatic high-grade stenosis.
  • Carotid artery stenting (CAS) offers a less invasive alternative for select patients.

Purpose of the Study:

  • To review the historical development of CAS.
  • To compare evidence from major clinical trials of CAS versus CEA.
  • To examine current practices in the context of advanced medical therapies.

Main Methods:

  • Comprehensive review of randomized trials, registries, and guidelines.
  • Synthesis of evidence on procedural outcomes and patient selection.
  • Inclusion of emerging technologies like transcarotid artery revascularization (TCAR).

Main Results:

  • CAS and CEA demonstrate similar long-term composite outcomes in selected patients.
  • CAS carries a higher peri-procedural stroke risk; CEA has higher myocardial infarction rates.
  • Advances in embolic protection and stent technology enhance endovascular approaches.

Conclusions:

  • Intensive medical therapy significantly reduces stroke risk, especially in asymptomatic individuals.
  • Optimal stroke prevention requires personalized, multidisciplinary decision-making.
  • Management integrates symptom status, anatomy, comorbidities, expertise, and risk factor control.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
493
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655